Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysisJiHoon Kang, Baek‐Yeol Ryoo, Jae Ho Jeong et al.|Investigational New Drugs|2018Cited by 148
FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinomaChanghoon Yoo, Baek‐Yeol Ryoo, Inhwan Hwang et al.|Therapeutic Advances in Medical Oncology|2020Cited by 35